Recent Updates — VSEEW

VSee Health, Inc. filed a Certificate of Amendment to effect a reverse stock split of its common stock in a ratio of 1-for-80. The split becomes effective at 5:00 p.m. Eastern Time on September 23, 2026, with split-adjusted trading commencing at market open on September 24, 2026. Fractional shares will be rounded up to the next whole number rather than paid in cash. The transaction was previously approved by the Board of Directors and stockholders, and no changes were made to authorized common or preferred share counts. VSee Health, Inc. operates in the healthcare technology sector.

VSee Health, Inc. received a notice from Nasdaq on July 30, 2026, that its securities will be delisted from the Nasdaq Capital Market due to a closing bid price of $0.10 or less for ten consecutive trading days. Trading of common stock and warrants is suspended at the opening of business on August 6, 2026. The company may appeal by submitting a request and a non-refundable fee of $20,000 to the Nasdaq Hearings Panel no later than 4:00 p.m. Eastern Time on August 6, 2026. VSee Health operates in the healthcare technology industry.

VSee Health, Inc. entered into a securities purchase agreement with Labrys on June 30, 2026, issuing an unsecured convertible promissory note with an aggregate principal amount of $336,000, which includes a $36,000 original issue discount. The note bears a one-time interest charge of twelve percent and is due on June 30, 2027. Conversion into common stock is permitted after the earlier of default, 180 days post-issuance, or registration of conversion shares, at a price equal to 75% of the lowest closing bid price over the preceding ten trading days. The company operates in the healthcare technology sector.